Suniti Medical Corporation
Suniti Medical Corporation was paid $4.22M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 17% of everything it billed.
33Billing provider infoSUNITI MEDICAL CORPORATION
MERRILLVILLE, IN 46410
MERRILLVILLE, IN 46410
33aNPI1285667550assigned 07/09/2006
33bProvider typeSpecialist
28Total paid$4.22M
24GClaims209,570
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Indiana
Rank by total paid#6 of 90
Median peer was paid$98K
This provider vs. median43×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,016 | $398K | |
| 2019 | 39,642 | $716K | |
| 2020 | 45,462 | $926K | |
| 2021 | 45,569 | $1.26M | |
| 2022 | 22,566 | $546K | |
| 2023 | 12,022 | $209K | |
| 2024incomplete | 8,293 | $161K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 14,257 | 11,548 | $729K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 20,242 | 11,102 | $688K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 14% | 12,862 | 5,714 | $586K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 7.2% | 10,570 | 3,405 | $306K |
| J9271 | Injection, pembrolizumab, 1 mg | 5.9% | 35 | 25 | $249K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.6% | 5,334 | 1,693 | $237K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5.6% | 7,339 | 3,897 | $235K |
| 96367 | 3.8% | 10,745 | 4,641 | $158K | |
| J1756 | Injection, iron sucrose, 1 mg | 3.4% | 4,958 | 2,351 | $143K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.2% | 37,913 | 21,537 | $136K |
| 99223 | Prolong inpt eval add15 m | 3.1% | 1,666 | 1,526 | $130K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.7% | 1,447 | 1,225 | $114K |
28 more codes
| J0897 | Injection, denosumab, 1 mg | 2.5% | 80 | $107K |
| 96417 | 1.9% | 2,869 | $81K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.8% | 3,881 | $78K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 38,426 | $62K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 6,385 | $45K |
| 96368 | <1% | 5,013 | $40K | |
| 96415 | <1% | 1,767 | $32K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,793 | $20K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 69 | $9K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 1,020 | $9K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 36 | $6K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 8,971 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,403 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 41 | $3K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,661 | $2K |
| 96411 | <1% | 47 | $2K | |
| 90756 | <1% | 117 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,216 | $1K |
| 99219 | <1% | 12 | $785.26 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 75 | $695.85 |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 101 | $606.79 |
| J9045 | Injection, carboplatin, 50 mg | <1% | 24 | $234.92 |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 19 | $230.44 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 23 | $143.42 |
| 90688 | <1% | 21 | $141.93 | |
| 36591 | <1% | 92 | $48.06 | |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 23 | $42.79 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 17 | $25.43 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBENDT, PEGGY (OFFICE MANAGER)